Revance Therapeutics shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $424k | 37k | 11.47 |
| 2023-06-30 | $937k | 37k | 25.31 |
| 2023-03-31 | $1.2M | 37k | 32.21 |
| 2022-12-31 | $683k | 37k | 18.46 |
| 2022-09-30 | $589k | 22k | 27.02 |
| 2022-06-30 | $301k | 22k | 13.81 |
| 2022-03-31 | $425k | 22k | 19.50 |
| 2021-12-31 | $216k | 13k | 16.33 |